摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Methyl 4-O-(5a-carba-α-D-glucopyranosyl)-α-D-glucopyranoside | 152203-02-6

中文名称
——
中文别名
——
英文名称
Methyl 4-O-(5a-carba-α-D-glucopyranosyl)-α-D-glucopyranoside
英文别名
Kuufqkoonfrgtp-gtoarbiisa-;(1R,2S,3R,4S,6R)-4-[(2R,3S,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxy-6-(hydroxymethyl)cyclohexane-1,2,3-triol
Methyl 4-O-(5a-carba-α-D-glucopyranosyl)-α-D-glucopyranoside化学式
CAS
152203-02-6
化学式
C14H26O10
mdl
——
分子量
354.354
InChiKey
KUUFQKOONFRGTP-GTOARBIISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -3.6
  • 重原子数:
    24
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    169
  • 氢给体数:
    7
  • 氢受体数:
    10

反应信息

点击查看最新优质反应信息

文献信息

  • Convenient Synthesis of Oxo-Linked 5a-Carba-di- and tri-saccharides of Biological Interests
    作者:Seiichiro Ogawa、Shin-ichi Sasaki、Hidetoshi Tsunoda
    DOI:10.1246/cl.1993.1587
    日期:1993.9
    Some oxo-linked 5a-carba-di- and tri-saccharides of biological interests including 5a-carbamaltose, were synthesized by coupling of 5a-carba-glycosyl donor, 1,2-anhydro-5a-carba-β-d-mannopyranose derivative with the alkoxides generated from the protected hexopyranose derivatives in N,N-dimethylformamide in the presence of a crown ether.
    一些具有生物学意义的氧键连接的5a-carba二糖和三糖,包括5a-carbamaltose,通过在N,N-二甲基甲酰胺中使用冠醚的存在,将5a-carba-糖苷供体1,2-脱-5a-carba-β-d-甘露糖喃糖衍生物与保护的六元喃糖衍生物生成的醇盐结合合成。
  • Methods and Compositions for Therapeutic Treatment
    申请人:Robbins Wendye
    公开号:US20080161248A1
    公开(公告)日:2008-07-03
    Methods and compositions are described for the modulation of central nervous system and/or fetal effects of calcineurin inhibitors. Methods and compositions are described for the modulation of efflux transporter activity to increase the efflux of calcineurin inhibitors out of a physiological compartment and into an external environment. In particular, the methods and compositions disclosed herein provide for the increase of efflux transporter activity at Blood-Tissue, blood-CSF and placental-maternal barriers to increase the efflux of calcineurin inhibitor from physiological compartments, including central nervous system and fetal compartments.
查看更多